NLS Acquisition

Elos Medtech has entered into an agreement to acquire Klingel Holding from IK Partners and management. Klingel, a leading contract development and manufacturing organization (CDMO) headquartered in Germany, will strengthen Elos Medtech’s position with extraordinary R&D capabilities and new technology expertise, the company states. Further, the acquisition will broaden the product offering and add new […]

Alexion, AstraZeneca Rare Disease, has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer. The agreement furthers Alexion and AstraZeneca’s commitment to advancing next-generation genomic medicines with the addition of complementary pipeline assets and innovative technologies, it states. Alexion will purchase and licence the […]

NorthX Biologics has acquired the Stockholm-based Clinical Trial Manufacturing unit from Valneva Sweden. The acquisition includes the transfer of a multi-purpose facility, situated in the Stockholm life science cluster, close to Karolinska University Hospital. In addition, 30 staff members who currently operate the facility will also join NorthX. “We are delighted to join forces with […]

Swedish Orphan Biovitrum and CTI BioPharma have announced the completion of the acquisition of CTI by Sobi through its indirect wholly owned subsidiary Cleopatra Acquisition Corp (Cleopatra). Following the completion of Sobi’s successful tender offer to purchase all outstanding shares of common stock of CTI for USD 9.10 per share in cash, net to the […]

Novartis has entered into an agreement to acquire Chinook Therapeutics, a Seattle, WA, based clinical stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney diseases. The agreed deal, which is subject to customary closing conditions, is fully in line with Novartis strategy to focus on innovative medicines and will […]

Novo Nordisk has entered into exclusive negotiations for a controlling stake in Biocorp, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in the company at a price of 35 EUR per share in cash, representing a total equity value of approximately 154 million EUR. Biocorp is a French […]